• BX Home
  • Abbott Laboratories: News [Page 20]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ABBOTT LABORATORIES

Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.

Abbott Laboratories is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 921 news and 191 blog items. Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from like-minded professionals.

News

Please add new articles to this topic

Orexigen diet pill wins US advisory panel backingmore

animal studies, and Vivus was asked for more data on heart risks with its medicine. Also in October, Abbott...

Abbott Stenting Scandal Sounds Like Tenet All Over Againmore

disclosure led to an avalanche of malpractice claims. The public company implicated in the Baltimore stenting case is...

Abbott Hired Barred Doctormore

BY ALICIA MUNDY AND THOMAS M. BURTON Abbott Laboratories hired a Baltimore-area cardiologist as a sales consultant...

Citi selling Turkish drugmaker Biofarma - sourcesmore

looking to build a base in Turkey, whose pharmaceutical market is growing more than 7 percent a year. Abbott...

November's Best- and Worst-Performing Biotech Stocksmore

oil formulation for lowering triglycerides. It would compete with Lovaza, sold by GlaxoSmithKline in the U.S.

Lubiprostone Successfully Completes Long-Term Phase 3 Safety Trial In ...more

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a...

An ETF offering a healthy discount on big drug stocksmore

Johnson JNJ-N (almost 13 per cent of assets), Pfizer PFE-N (10 per cent), Merck MRK-N (8 per cent), Abbott Laboratories...

Windfall for local biotech after sex drug gets US approvalmore

meant that their product is easily transferred to others by hand (such as partners or children). Market leader Abbott...

Jim Cramer's Best Blogsmore

and the astounding run of Edwards Lifesciences(EW). The resurgence does not include old-line pharma, where even...

Testosterone supplement gains US approvalmore

applications which means they are easily transferred to others by hand and have strong smells. The market leader,...

Why does Buffett still like Washington Post?more

are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney.com, and Abbott Laboratories, La...

Merck to launch new drugs in Indiamore

the ability to sell drugs made by Indian pharamaceutical companies, has been driving cross-border deals in the sector.

Merck to launch new drugs in India, seeks partnermore

the ability to sell drugs made by Indian pharamaceutical companies, has been driving cross-border deals in the sector.

Is Abbott Labs the Perfect Stock? (ABT, ARNA, JNJ, MRK, PFE, VVUS)more

The Motley Fool - Finding companies that have all the right stuff can produce winners.

Human Genome May Be Takeover Target If FDA Backs Drugmore

an analyst at RBC Capital Markets in San Francisco. Other potential buyers include Amgen Inc., Roche Holding AG, Abbott...

Top drug recalls a bitter pill for consumersmore

third quarter due to its recall of nearly 200 million bottles of different over-the-counter drugs.| ad info Abbott...

Are You Missing Something Easy at Abbott Laboratories?more

Margins matter. The more Abbott Laboratories (NYSE: ABT) Here's the current margin snapshot for Abbott Laboratories and...

Investing in Johnson & Johnson While Still Enjoying Diversificatio...more

that is invested in other big pharma players such as Pfizer (which comprises 19% of assets), Merck (17%), Abbott...

Investors wade cautiously into stocksmore

of 2.5 to 3.5 percent. Companies meeting these criteria include Intel Corp, Johnson & Johnson and Abbott...

Wealthy US investors getting back into stocksmore

and a dividend yield of 2.5-3.5%. Companies meeting these criteria include Intel, Johnson & Johnson and Abbott...

Abbott's Dividends May Not Last Forevermore

company is likely to continue paying its dividend. Today, let's drill beneath the surface and check out Abbott...

UPDATE 3-U.S. FDA warns of prostate cancer drug risksmore

* Drugs include Abbott's Lupron, Sanofi's Eligard (Adds Abbott spokeswoman) WASHINGTON The medications include Abbott...

UPDATE 2-U.S. FDA warns of prostate cancer drug risksmore

of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday. The medications include...

FDA orders new warnings on prostate cancer drugsmore

of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday. The medications include Abbott...

Abbott: Current Challenges and Future Developments for Drug Safety in ...more

Drug safety has never been more important. Patient's attitudes to risk have changed significantly and negavtive...

Top Sources: Abbott Laboratories

  • BusinessWeek
  • MarketWatch
  • Reuters
  • Chicago Tribune
  • thedeal.com
  • chicagobusiness.com
  • CNN Money
  • TheStreet.com
  • CNBC
  • innovationexcellence.com

Most Active Users in this Topic

see all contributors in Abbott Laboratories

Featured White Papers

Post a Job

Jobs in this Topic

Director, Laboratory Operations Abbott Laboratories | Irvine, CA
Posted: Jan 30
SR REGULATORY AFFAIRS SPECIALIST Abbott Laboratories | Santa Clara, CA
Posted: Mar 4
WAREHOUSE SUPERVISOR Abbott Laboratories | Milpitas, CA
Posted: May 2
Project Manager, Commercial Abbott Laboratories | Santa Ana, CA
Posted: Apr 26
Sr Product Manager, US Endovascular Abbott Laboratories | Santa Clara, CA
Posted: May 13

Report comment contains invalid characters. ()
cancel
Search Cancel